SCHEMBL25600975

SCHEMBL25600975

CNC(=O)/C(=N/OC)c1cccc(C)c1CO/N=C(\C)c1cc(F)ccc1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 4/20 0.34
CA12 O43570 1/20 0.33
RAB9A P51151 3/20 0.32
NPC1 O15118 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
CXCR5 P32302 4/20 0.32
CRHR1 P34998 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
PKM P14618 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
AVPR2 P30518 1/20 0.31
OXTR P30559 1/20 0.31
AVPR1A P37288 1/20 0.31
KDM4E B2RXH2 1/20 0.30
GAA P10253 1/20 0.30
STAT1 P42224 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23971893 0.93 HIF1A (0.34) HIF1ACA12RAB9ANPC1CXCR5
SCHEMBL25600970 0.92 HIF1A (0.33) HIF1ACA12RAB9ANPC1CXCR5
SCHEMBL23971771 0.92 F2R (0.33) HIF1ACA12RAB9ANPC1CXCR5
SCHEMBL23971863 0.91 KDM4E (0.39) HIF1ACA12CXCR5CRHR1KDM4E
SCHEMBL23971888 0.91 HIF1A (0.38) HIF1ARAB9ANPC1KMT2APOLB
SCHEMBL23971865 0.90 HIF1A (0.35) HIF1ARAB9ANPC1KMT2APOLB
SCHEMBL23971934 0.90 MAPK13 (0.35) HIF1ACA12CXCR5AVPR2OXTR
SCHEMBL25551488 0.89 HIF1A (0.35) HIF1ACA12
SCHEMBL25720561 0.89 HIF1A (0.34) HIF1ACA12RAB9ANPC1CXCR5
SCHEMBL23972038 0.89 HIF1A (0.42) HIF1ARAB9ANPC1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172206-A1 USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS II BASF SE (DE) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172206-A1 USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS II COX5B, SQOR, UQCRB HIF1A 2078/4885CA12 2892/4885RAB9A 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.